Finnish congenital nephrotic syndrome: genes and variants

Explore variant evidence for Finnish congenital nephrotic syndrome across 2 analyzed proteins (NPHS1, NPHS2). Linked ClinVar records include 71 pathogenic or likely pathogenic variants, 152 variants of uncertain significance and 60 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Finnish congenital nephrotic syndrome

ClinVar pathogenic and likely pathogenic variants linked to Finnish congenital nephrotic syndrome

VariantPositionProtein partClinical label
NPHS1 P368L368Ig-like C2-type 4Pathogenic / likely pathogenic (★★)
NPHS1 P368S368Ig-like C2-type 4Pathogenic / likely pathogenic (★★)
NPHS1 V736A736ExtracellularPathogenic / likely pathogenic (★★)
NPHS1 S366R366Ig-like C2-type 4Pathogenic / likely pathogenic (★★)
NPHS1 R711S711ExtracellularPathogenic / likely pathogenic (★★)
NPHS1 R711H711ExtracellularPathogenic / likely pathogenic (★★)
NPHS1 C623F623Ig-like C2-type 6Pathogenic / likely pathogenic (★★)
NPHS1 V709G709ExtracellularPathogenic / likely pathogenic (★★)
NPHS2 R168H168CytoplasmicPathogenic / likely pathogenic (★★)
NPHS1 P167L167Ig-like C2-type 2Pathogenic / likely pathogenic (★★)
NPHS1 R367C367Ig-like C2-type 4Pathogenic / likely pathogenic (★★)
NPHS1 L587R587Ig-like C2-type 6Pathogenic / likely pathogenic (★★)
NPHS1 G796R796Ig-like C2-type 7Pathogenic / likely pathogenic (★★)
NPHS1 G867D867Ig-like C2-type 8Pathogenic / likely pathogenic (★★)
NPHS1 L96V96Ig-like C2-type 1Pathogenic / likely pathogenic (★★)
NPHS1 G270C270Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
NPHS1 S572N572Ig-like C2-type 6Pathogenic / likely pathogenic (★★)
NPHS1 G796E796Ig-like C2-type 7Pathogenic / likely pathogenic (★★)
NPHS1 R831C831ExtracellularPathogenic / likely pathogenic (★★)
NPHS1 D105N105Ig-like C2-type 1Pathogenic / likely pathogenic (★★)
NPHS1 R802W802Ig-like C2-type 7Pathogenic / likely pathogenic (★★)
NPHS1 R888K888Ig-like C2-type 8Pathogenic / likely pathogenic (★★)
NPHS1 Y977C977Fibronectin type-IIIPathogenic / likely pathogenic (★★)
NPHS1 M1T1Pathogenic / likely pathogenic (★★)
NPHS1 D310N310Ig-like C2-type 3Pathogenic / likely pathogenic (★★)
NPHS1 S350P350Ig-like C2-type 4Pathogenic / likely pathogenic (★★)
NPHS1 R407W407Ig-like C2-type 4Pathogenic / likely pathogenic (★★)
NPHS1 R460Q460Ig-like C2-type 5Pathogenic / likely pathogenic (★★)
NPHS1 P519S519Ig-like C2-type 5Pathogenic / likely pathogenic (★★)
NPHS1 R743C743Ig-like C2-type 7Pathogenic / likely pathogenic (★★)
NPHS1 A806D806Ig-like C2-type 7Pathogenic / likely pathogenic (★★)
NPHS1 S910P910Ig-like C2-type 8Pathogenic / likely pathogenic (★★)
NPHS1 V822M822ExtracellularPathogenic / likely pathogenic (★★)
NPHS1 R711C711ExtracellularPathogenic / likely pathogenic (★)
NPHS1 V736M736ExtracellularPathogenic / likely pathogenic (★)
NPHS1 V834F834ExtracellularPathogenic / likely pathogenic (★)
NPHS1 P674L674ExtracellularPathogenic / likely pathogenic (★)
NPHS1 C160S160Ig-like C2-type 2Pathogenic / likely pathogenic (★)
NPHS1 L334P334ExtracellularPathogenic / likely pathogenic (★)
NPHS1 A672T672ExtracellularPathogenic / likely pathogenic (★)
NPHS1 C265R265Ig-like C2-type 3Pathogenic / likely pathogenic (★)
NPHS1 C465Y465Ig-like C2-type 5Pathogenic / likely pathogenic (★)
NPHS1 S569R569Ig-like C2-type 6Pathogenic / likely pathogenic (★)
NPHS1 P838T838Ig-like C2-type 8Pathogenic / likely pathogenic (★)
NPHS1 C863R863Ig-like C2-type 8Pathogenic / likely pathogenic (★)
NPHS1 V957E957Fibronectin type-IIIPathogenic / likely pathogenic (★)
NPHS1 G967R967Fibronectin type-IIIPathogenic / likely pathogenic (★)
NPHS1 P243L243Ig-like C2-type 3Pathogenic / likely pathogenic (★)
NPHS1 R976S976Fibronectin type-IIIPathogenic / likely pathogenic (★)
NPHS1 N673K673ExtracellularPathogenic / likely pathogenic
NPHS1 A739V739ExtracellularPathogenic / likely pathogenic
NPHS1 I742T742Ig-like C2-type 7Pathogenic / likely pathogenic
NPHS1 R802P802Ig-like C2-type 7Pathogenic / likely pathogenic
NPHS1 W64S64Ig-like C2-type 1Pathogenic / likely pathogenic
NPHS1 C528F528Ig-like C2-type 5Pathogenic / likely pathogenic
NPHS1 L643P643ExtracellularPathogenic / likely pathogenic
NPHS1 W681C681ExtracellularPathogenic / likely pathogenic
NPHS1 L832P832ExtracellularPathogenic / likely pathogenic
NPHS1 I171N171Ig-like C2-type 2Pathogenic / likely pathogenic
NPHS1 I173N173Ig-like C2-type 2Pathogenic / likely pathogenic

Showing 60 of 71.

Uncertain variants prioritized for review in Finnish congenital nephrotic syndrome

VariantPositionProtein partClinical labelEvidence
NPHS1 S572G572Ig-like C2-type 6Conflicting reports (★)+6: 3 other pathogenic changes within 3 positions; S572N at the same position is pathogenic; seen in 4.1e-06 of gnomAD DNA copies; REVEL 0.666

Which prediction tools work for Finnish congenital nephrotic syndrome

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Finnish congenital nephrotic syndrome

Frequently asked questions

Which genes have records linked to Finnish congenital nephrotic syndrome?

This view contains 2 analyzed proteins: NPHS1, NPHS2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 71 pathogenic or likely pathogenic variants, 152 variants of uncertain significance and 60 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 287 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center